Gene study in first acute ischemic stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study looks at how a gene called GGCX might affect recovery in people who have just had an ischemic stroke. By studying this gene, doctors hope to understand why some people do better than others and maybe find new ways to guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 85 years old.
- You must have had your first-ever acute ischemic stroke (stroke from a blocked blood vessel), with symptoms starting within the last 3 days.
- You must not have other types of stroke, such as bleeding in the brain or stroke caused by a tumor.
- You must not have blood clotting disorders or other blood diseases.
- You must not have severe heart, lung, or liver disease, kidney failure, active cancer, or bleeding stomach ulcers.
- If you are pregnant or breastfeeding, you cannot take part in this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether MT200605 can help people who recently had an ischemic stroke (a type of stroke caused by a blocked blood vessel). The drug is given within 24 hours of symptoms starting, and you may join even if you received clot-busting treatment already.
This study looks at how well early treatment works for people having their first stroke. It may help doctors understand what treatments help the most soon after a stroke starts.
This study tests a structured, fast way of treating people who have a new ischemic stroke (a stroke caused by a blocked blood vessel). It may help because it focuses on getting the right stroke treatments quickly and consistently.
This trial tests whether a cholesterol-lowering medication called evolocumab (a PCSK9 inhibitor) can help people recover better after a specific type of stroke caused by clogged arteries. The study checks if lowering cholesterol further than usual statins do improves stroke outcomes and is safe.
This study looks at how genes might influence stroke risk by comparing the DNA of people who have had a stroke with similar people who haven't. Your participation could help researchers understand why strokes happen and lead to better prevention.
This study looks at people who have had an ischemic stroke (a type caused by a blocked blood vessel). It is collecting information over time to better understand care needs and follow-up after stroke.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.